Clinical Trial Update: Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating cardiac changes after an effective dose of carbetocin for elective cesarean section; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Carbetocin (carbetocin)

Snippet

Sponsor: Jordan Leitch | Conditions: Cardiac Ischemia, Cesarian Section | Phase 4 | Status: NOT_YET_RECRUITING